Modeling medical treatment using Markov decision processes AJ Schaefer, MD Bailey, SM Shechter, MS Roberts Operations research and health care: A handbook of methods and applications …, 2004 | 256 | 2004 |
The optimal time to initiate HIV therapy under ordered health states SM Shechter, MD Bailey, AJ Schaefer, MS Roberts Operations Research 56 (1), 20-33, 2008 | 214 | 2008 |
Estimating the impact of alcohol consumption on survival for HIV+ individuals RS Braithwaite, J Conigliaro, MS Roberts, S Shechter, A Schaefer, ... AIDS care 19 (4), 459-466, 2007 | 161 | 2007 |
A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process SM Shechter, CL Bryce, O Alagoz, JE Kreke, JE Stahl, AJ Schaefer, ... Medical Decision Making 25 (2), 199-209, 2005 | 149 | 2005 |
Prospect theory and the newsvendor problem M Nagarajan, S Shechter Management Science 60 (4), 1057-1062, 2014 | 135 | 2014 |
The use of discrete-event simulation modelling to improve radiation therapy planning processes G Werker, A Sauré, J French, S Shechter Radiotherapy and Oncology 92 (1), 76-82, 2009 | 110 | 2009 |
A methodological framework for optimally reorganizing liver transplant regions JE Stahl, N Kong, SM Shechter, AJ Schaefer, MS Roberts Medical Decision Making 25 (1), 35-46, 2005 | 91 | 2005 |
Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model RS Braithwaite, MS Roberts, CCH Chang, MB Goetz, CL Gibert, ... Annals of internal medicine 148 (3), 178-185, 2008 | 89 | 2008 |
Timing of arteriovenous fistula creation in patients with CKD: a decision analysis SM Shechter, MR Skandari, N Zalunardo American journal of kidney diseases 63 (1), 95-103, 2014 | 81 | 2014 |
Incorporating biological natural history in simulation models: empirical estimates of the progression of end-stage liver disease O Alagoz, CL Bryce, S Shechter, A Schaefer, CCH Chang, DC Angus, ... Medical Decision Making 25 (6), 620-632, 2005 | 69 | 2005 |
Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation RS Braithwaite, S Shechter, MS Roberts, A Schaefer, DR Bangsberg, ... Journal of Antimicrobial Chemotherapy 58 (5), 1036-1043, 2006 | 67 | 2006 |
Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques SM Shechter, AJ Schaefer, RS Braithwaite, MS Roberts Medical Decision Making 26 (5), 550-553, 2006 | 38 | 2006 |
SPAR: stochastic programming with adversarial recourse MD Bailey, SM Shechter, AJ Schaefer Operations Research Letters 34 (3), 307-315, 2006 | 38 | 2006 |
Estimating the rate of accumulating drug resistance mutations in the HIV genome RS Braithwaite, S Shechter, CCH Chang, A Schaefer, MS Roberts Value in Health 10 (3), 204-213, 2007 | 36 | 2007 |
Screening strategies for patients on the kidney transplant waiting list A Sabouri, WT Huh, SM Shechter Operations Research 65 (5), 1131-1146, 2017 | 23 | 2017 |
Patient-type Bayes-adaptive treatment plans MR Skandari, SM Shechter Operations research 69 (2), 574-598, 2021 | 18 | 2021 |
A modeling framework for replacing medical therapies SM Shechter, MD Bailey, AJ Schaefer IIE Transactions 40 (9), 861-869, 2008 | 18 | 2008 |
Optimal vascular access choice for patients on hemodialysis MR Skandari, SM Shechter, N Zalunardo Manufacturing & Service Operations Management 17 (4), 608-619, 2015 | 16 | 2015 |
Setting sites for faster results: Optimizing locations and capacities of new tuberculosis testing laboratories F Saveh-Shemshaki, S Shechter, P Tang, J Isaac-Renton IIE Transactions on Healthcare Systems Engineering 2 (4), 248-258, 2012 | 16 | 2012 |
Forecasting the effect of physician assistants in a pediatric ED Q Doan, W Hall, S Shechter, N Kissoon, S Sheps, J Singer, H Wong, ... JAAPA 27 (8), 35-41, 2014 | 15 | 2014 |